FiercePharma4h
Fierce Pharma Asia—Eisai's US restructuring; China investigates former NMPA official; Pfizer-Summit collab
Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by ...
centerforbiosimilars5h
The Top 5 Biosimilar Articles for the Week of February 24
Number 4: Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept ...
Johnson & Johnson’s DARZALEX SC gets positive CHMP opinion
Janssen-Cilag International NV, a Johnson & Johnson company (NYSE:JNJ) announced Friday that an expert panel of the EU drug ...
Key Themes, Strategic Moves, and Market Dynamics from JP Morgan's 43rd Annual Healthcare Conference, January 13-16, 2025
The "43rd Annual JP Morgan Healthcare Conference, January 13-16, 2025" report has been added to ResearchAndMarkets.com's offering.The 43rd Annual JP Morgan Healthcare Conference took place in San ...